Rallis India Ltd Valuation Shifts to Attractive Amidst Challenging Market Returns

Valuation Metrics Reflect Improved Attractiveness

Rallis India’s price-to-earnings (P/E) ratio currently stands at 16.19, a figure that has moved the stock’s valuation grade from very attractive to attractive. This shift suggests that while the stock remains reasonably priced relative to its earnings, the margin of undervaluation has narrowed compared to historical levels. The price-to-book value (P/BV) ratio is at 1.90, indicating that the stock trades at nearly twice its book value, a moderate premium that aligns with sector norms.

Other valuation multiples reinforce this perspective. The enterprise value to EBITDA (EV/EBITDA) ratio is 8.45, which is notably lower than many peers, signalling a relatively cheaper operational valuation. The EV to EBIT ratio is 12.04, and EV to sales is 1.13, both suggesting that the market is pricing Rallis India with some caution, likely reflecting concerns about near-term earnings growth and sector cyclicality.

Comparative Peer Analysis Highlights Relative Value

When compared with key competitors in the pesticides and agrochemicals industry, Rallis India’s valuation stands out as attractive. Bayer CropScience and BASF India, for instance, trade at P/E ratios of 21.79 and 23.67 respectively, with EV/EBITDA multiples of 16.21 and 14.91. These higher multiples indicate that the market currently values these peers at a premium, possibly due to stronger growth prospects or superior market positioning.

Conversely, companies like Anupam Rasayan and Laxmi Organic are classified as very expensive, with P/E ratios exceeding 40 and EV/EBITDA multiples above 20, reflecting elevated expectations that may be difficult to sustain. On the other end of the spectrum, Sharda Cropchem and Dhanuka Agritech are considered very attractive, with P/E ratios of 10.25 and 14.09 and EV/EBITDA multiples of 5.57 and 9.92 respectively, underscoring a wide valuation range within the sector.

Rallis India’s PEG ratio of 0.40 further supports the notion of undervaluation relative to earnings growth, especially when compared to Bayer CropScience’s 0.92 and Anupam Rasayan’s 2.05. This low PEG ratio suggests that the stock’s price growth has not fully caught up with its earnings potential, although the recent downgrade in Mojo Grade tempers enthusiasm.

Financial Performance and Returns Contextualise Valuation

Rallis India’s return on capital employed (ROCE) is 13.98%, while return on equity (ROE) stands at 11.75%. These figures indicate moderate efficiency in generating returns from capital and equity, though they trail some of the more aggressive peers in the sector. The dividend yield of 1.50% adds a modest income component for investors, but is unlikely to be a primary attraction given the stock’s valuation and growth profile.

Examining stock price performance relative to the broader market reveals a challenging period for Rallis India. Year-to-date, the stock has declined by 28.64%, significantly underperforming the Sensex’s 15.62% fall. Over the past year, the stock’s return is down 35.45%, compared to the Sensex’s 11.20% gain. Even over longer horizons such as five and ten years, Rallis India has lagged the benchmark, with five-year returns at -29.90% versus Sensex’s 22.37%, and ten-year returns at -10.41% against a robust 158.06% for the index.

Market Capitalisation and Trading Range Insights

Rallis India is classified as a small-cap stock, with a current price of ₹199.75, marginally down 0.03% from the previous close of ₹199.80. The stock’s 52-week high was ₹315.50, while the low was ₹196.70, indicating a significant retracement from its peak levels. Today’s trading range has been relatively narrow, between ₹197.25 and ₹200.55, reflecting subdued volatility amid cautious investor sentiment.

The downgrade in Mojo Grade from Hold to Sell on 24 February 2026 underscores the market’s tempered outlook on the stock’s near-term prospects. The current Mojo Score of 43.0 aligns with this view, signalling below-average momentum and quality metrics relative to the broader market and sector peers.

Valuation Shifts Reflect Sector and Company-Specific Challenges

The transition of Rallis India’s valuation grade from very attractive to attractive suggests that while the stock remains reasonably priced, the margin of safety has diminished. This change may be attributed to a combination of factors including subdued earnings growth, competitive pressures within the pesticides and agrochemicals sector, and broader macroeconomic uncertainties impacting agricultural input demand.

Investors should note that while Rallis India’s valuation metrics remain favourable relative to many peers, the stock’s historical underperformance and recent downgrade in quality ratings warrant a cautious approach. The company’s operational metrics such as ROCE and ROE, while respectable, do not currently justify a premium valuation, especially in light of the sector’s cyclical nature and evolving regulatory landscape.

Investor Takeaway: Balancing Valuation and Growth Prospects

For investors evaluating Rallis India, the current valuation presents a nuanced picture. The stock’s attractive P/E and EV/EBITDA multiples relative to peers suggest potential value, especially given the low PEG ratio indicating earnings growth is not fully priced in. However, the company’s recent downgrade in Mojo Grade to Sell and its underwhelming price performance relative to the Sensex highlight risks that cannot be ignored.

Given the sector’s inherent cyclicality and the competitive pressures faced by Rallis India, investors should weigh the stock’s valuation appeal against its growth trajectory and quality metrics. The moderate returns on capital and equity, combined with a modest dividend yield, suggest that while the stock may offer value, it is unlikely to be a high-growth or high-income proposition in the near term.

Ultimately, Rallis India’s shift from very attractive to attractive valuation status signals a market reassessment that favours caution. Investors seeking exposure to the pesticides and agrochemicals sector may consider diversifying across peers with stronger growth profiles or more robust quality grades to optimise portfolio outcomes.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today